Vulnerabilities discovered in a subset of acute myeloid leukaemia (AML) could lead to new and effective treatments, US researchers have reported.
The team of scientists found that in both mouse and human models of AML with IDH mutations, arsenic t...
5 years ago
A new therapeutic target has been identified which could be the key to halting progression of acute myeloid leukaemia (AML) in almost one-fifth of patients, researchers have reported.
Researchers from the Cincinnati Children’s Hospital Medical Cen...
5 years ago
